Massa E, Michailidou E, Agapakis D, Papadopoulos S, Tholioti T, Aleuroudis I, Bargiota T, Passakiotou M, Daoudaki M, Antoniadis N, Imvrios G, Iosifidis E, Vagdatli E, Roilides E, Vasilakos D, Fouzas I, Mouloudi E
Intensive Care Unit, Hippokratio General Hospital, Thessaloniki, Greece.
Intensive Care Unit, Hippokratio General Hospital, Thessaloniki, Greece.
Transplant Proc. 2019 Mar;51(2):454-456. doi: 10.1016/j.transproceed.2019.01.076. Epub 2019 Jan 28.
Infections due to extensively drug resistant Gram-negative bacteria (GNB) after solid organ transplantation are increasing in prevalence and are associated with high morbidity and mortality. Surveillance culture (SC) seems to be an important tool for extensively drug resistant GNB control. The aim of this study was to evaluate colonization rates and subsequent infections by XDR-GNB in liver transplant recipients.
This was a prospective cohort study in patients who underwent liver transplantation (LT) between January 2016 and January 2018. Data on demographics, extensively drug resistant colonization, and 3-month clinical outcomes were obtained. Colonization was defined as a positive surveillance culture (SC-perirectal) immediately before transplantation, once weekly after LT, and after intensive care unit discharge, with emphasis to carbapenem-resistant Gram-negative bacteria (CR-GNB).
Forty-four patients who underwent LT were included in the study. Ten patients (22.72%) were colonized with CR-GNB prior to transplantation, and 7/10 (70%) developed infection due to the same pathogen (5 patients bloodstream infections, 2 patients pneumonia) during the study period. Intensive care unit length of stay was significantly longer in colonized with CR-GNB patients (P < .05). Mortality rate was higher in colonized patients (30%) than in noncolonized (11.76%) (P = .2).
Our study results suggest an overall 70% risk of CR-GNB infection among colonized patients. Given the high mortality rate and the difficulty in treating these infections, further research to investigate and develop strategies to eliminate the colonization is needed.
实体器官移植后广泛耐药革兰氏阴性菌(GNB)感染的患病率正在上升,且与高发病率和死亡率相关。监测培养(SC)似乎是控制广泛耐药GNB的重要工具。本研究的目的是评估肝移植受者中广泛耐药GNB的定植率及随后的感染情况。
这是一项对2016年1月至2018年1月期间接受肝移植(LT)患者的前瞻性队列研究。获取了人口统计学数据、广泛耐药定植情况以及3个月的临床结局数据。定植定义为移植前、LT后每周一次以及重症监护病房出院后直肠周围监测培养(SC)呈阳性,重点关注耐碳青霉烯革兰氏阴性菌(CR-GNB)。
44例接受LT的患者纳入研究。10例患者(22.72%)在移植前被CR-GNB定植,其中7/10(70%)在研究期间因相同病原体发生感染(5例血流感染,2例肺炎)。CR-GNB定植患者的重症监护病房住院时间明显更长(P <.05)。定植患者的死亡率(30%)高于未定植患者(11.76%)(P =.2)。
我们的研究结果表明,定植患者中CR-GNB感染的总体风险为70%。鉴于这些感染的高死亡率和治疗难度,需要进一步研究以调查和制定消除定植的策略。